Does adding MS-specific items to a generic measure (the SF-36) improve measurement?

被引:66
作者
Freeman, JA [1 ]
Hobart, JC [1 ]
Thompson, AJ [1 ]
机构
[1] UCL Inst Neurol, Neurol Outcome Measures Unit, London WC1N 3BG, England
关键词
D O I
10.1212/WNL.57.1.68
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The 36-item Short Form Health Survey Questionnaire (SF-36) is a widely used generic health status measure. Recently it has been adapted to produce a disease-specific measure for MS-the 54-item Multiple Sclerosis Quality of Life Scale (MSQOL-54)-composed of five unchanged SF-36 scales; three altered SF-36 scales (one item added to each scale); and five new scales incorporating 15 additional items. This study evaluates the impact of these additions by comparing the measurement properties of the MSQOL-54 with the SF-36. Methods: A total of 150 patients with MS, representing a broad spectrum of disease severity, completed a range of questionnaires, which included the MSQOL-54 (from which the SF-36 score was computed). Of these, 44 people completed the measures before and after inpatient rehabilitation to evaluate responsiveness. Standard psychometric methods were used to evaluate the measurement properties. Results: The measurement properties of the unchanged scales, inevitably, remain identical. Those of the three altered scales are virtually identical. Of the five new scales, the validity of the two sexual scales is questioned because of the high percentage of missing data, and the validity of the overall quality-of-life scale is limited as demonstrated by the low to moderate correlations with other related and unrelated measures. Responsiveness of the new scales also appears limited. Conclusion: Modifying existing measures by simply adding clinically chosen items may not be as useful. as anticipated in improving the measurement properties of an instrument.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 34 条
[1]  
*BRIT SOC REH MED, 1993, MULT SCL
[2]   Measurement of health related quality of life in multiple sclerosis patients [J].
Brunet, DG ;
Hopman, WM ;
Singer, MA ;
Edgar, CM ;
MacKenzie, TA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 23 (02) :99-103
[3]   Validation of the functional assessment of multiple sclerosis quality of life instrument [J].
Cella, DF ;
Dineen, K ;
Arnason, B ;
Reder, A ;
Webster, KA ;
Karabatsos, G ;
Chang, C ;
Lloyd, S ;
Mo, F ;
Stewart, J ;
Stefoski, D .
NEUROLOGY, 1996, 47 (01) :129-139
[4]   Recent developments in the assessment of quality of life in Multiple Sclerosis (MS) [J].
Fischer, JS ;
LaRocca, NG ;
Miller, DM ;
Ritvo, PG ;
Andrews, H ;
Paty, D .
MULTIPLE SCLEROSIS JOURNAL, 1999, 5 (04) :251-259
[5]  
Fitzpatrick R, 1998, Health Technol Assess, V2, P1
[6]  
Fletcher Astrid, 1992, British Medical Journal, V305, P1145
[7]   Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis [J].
Freeman, J ;
Hobart, JC ;
Langdon, DW ;
Thompson, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (02) :150-156
[8]   The impact of inpatient rehabilitation on progressive multiple sclerosis [J].
Freeman, JA ;
Langdon, DW ;
Hobart, JC ;
Thompson, AJ .
ANNALS OF NEUROLOGY, 1997, 42 (02) :236-244
[9]  
Freeman JA, 1996, J NEUROL REHABIL, V10, P185
[10]  
Goldberg D., 1991, A user's guide to the General Health Questionnaire